.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
QuintilesIMS
Merck
Queensland Health
US Department of Justice
Dow
Johnson and Johnson
Cerilliant
Medtronic

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020911

« Back to Dashboard
NDA 020911 describes QVAR 80, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug. Additional details are available on the QVAR 80 profile page.

The generic ingredient in QVAR 80 is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for 020911

Tradename:
2
Applicant:
1
Ingredient:
1
Patents:2
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020911

Suppliers and Packaging for NDA: 020911

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION 020911 NDA STAT RX USA LLC 16590-860 16590-860-71 1 CANISTER in 1 BOX (16590-860-71) > 100 AEROSOL, METERED in 1 CANISTER
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION 020911 NDA Physicians Total Care, Inc. 54868-5857 54868-5857-0 1 CANISTER in 1 BOX (54868-5857-0) > 100 AEROSOL, METERED in 1 CANISTER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.08MG/INH
Approval Date:Sep 15, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Dec 18, 2017Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.04MG/INH
Approval Date:Sep 15, 2000TE:RLD:Yes
Patent:► SubscribePatent Expiration:Dec 18, 2017Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 020911

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
Teva Branded Pharm
QVAR 80
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-001Sep 15, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Citi
Argus Health
Johnson and Johnson
Fuji
Queensland Health
McKesson
AstraZeneca
Mallinckrodt
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot